Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 1 of the last 4 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 43 % of short-term debt in 2022; threshold 65 %.
-
Legal situation KBO
Gerechtelijke ontbinding of nietigheid according to the CBE.
Financials
Financial year 2022
Phamily Pharma from Aalst, company number BE0865835955, closed financial year 2022 with a result of € -81,087 after tax. For that financial year Phamily Pharma recorded a gross margin of € -51,341 and equity of € -19,222. Compared with financial year 2021, the result moved from € 671 to € -81,087. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2023.
€ -19,222
▼ € 81,087 vs 2021
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -81,087
▼ still € 671 profit in 2021
Profit after tax over the fiscal year.
€ 3,939
▼ 58% vs 2021
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -25,422.
People and assets in 2022
€ 23,367
▼ 12% vs 2021
Book value of vehicles, furniture and equipment.
Debts at end 2022
€ 252,591
▼ 14% vs 2021
€ 12,444 is repaid this year. At this pace the long-term loan is gone in ≈ 20 years.
| 2019 | 2020 | 2021 | 2022 | Change 2021 → 2022 | |
|---|---|---|---|---|---|
| Gross margin | € 18,348 | € -64,847 | € 20,023 | € -51,341 | ▼ € 71,365 |
| Profit after taxes | € -3,998 | € -86,034 | € 671 | € -81,087 | ▼ € 81,758 |
| Equity | € 147,229 | € 61,195 | € 61,865 | € -19,222 | ▼ € 81,087 |
| Total debts | € 227,778 | € 369,045 | € 479,490 | € 429,078 | ▼ 11% |
| Cash | € 6,795 | € 16,427 | € 9,414 | € 3,939 | ▼ 58% |
| Land & buildings | - | € 107,695 | € 155,704 | € 219,934 | ▲ 41% |
| Retained profit | € 141,029 | € 54,995 | € 55,665 | € -25,422 | ▼ € 81,087 |
| Bank debt | € 111,230 | € 111,230 | € 294,603 | € 252,591 | ▼ 14% |
| Balance sheet total | € 375,007 | € 430,240 | € 541,355 | € 409,856 | ▼ 24% |
By gross margin, Phamily Pharma ranks 17th of 17 companies with main activity “Detailhandel in farmaceutische producten” in Aalst that publish figures (fiscal year 2022).
Key figures of Phamily Pharma, fiscal years 2019 to 2022, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2023 has not been filed yet; it was expected before 31 July 2024.
Ask about Phamily Pharma the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Phamily Pharma?
What happened at Phamily Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
Phamily Pharma is active according to the CBE. Legal situation: Gerechtelijke ontbinding of nietigheid.
- New annual accounts for financial year 2022: loss of € 81,087 (▼ € 81,758 vs 2021). filed late Source: NBB ↗
- New establishment in Erpe-Mere. KBO
- Start of the company according to the CBE. KBO
In short
From € 3,998 loss in 2019 to € 81,087 loss in 2022.
Paid € 12,432 in corporate taxes since 2019.
Best year ever: 2021, with € 671 profit.
Establishments
Establishment units
Physical locations of this company
Boudewijnlaan 188 box A
9300 Aalst
Kraaineststraat 35
9420 Erpe-Mere
Active since 16 July 2004
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Aalst
Same main activity (Detailhandel in farmaceutische producten), 18 active companies in Aalst, largest first.
€ 289,996 gross margin · 2025
€ 171,509 gross margin · 2025
€ 170,570 gross margin · 2025
€ 170,258 gross margin · 2025
€ 153,744 gross margin · 2025
€ 144,920 gross margin · 2025
Details
- Company number
- 0865.835.955
- VAT number
- BE 0865.835.955
- Registered office
- Boudewijnlaan 188 bus A, 9300 Aalst
- Names & denominations
- Phamily Pharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Gerechtelijke ontbinding of nietigheid
- Start date
- 17 June 2004
- Peppol
- Not registered
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers